Constitutive IκB kinase activity correlates with nuclear factor-κB activation in human melanoma cells

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4901-4909

  Yang, J ^a   Richmond, A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE; ALPHA CHEMOKINE; CHEMOTACTIC FACTOR; CHUK PROTEIN, HUMAN; CXCL1 PROTEIN, HUMAN; DNA BINDING PROTEIN; GROWTH PROMOTOR; I KAPPA B; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; INTERLEUKIN 1; LUCIFERASE; MESSENGER RNA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CYTOPLASM; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROMOTER REGION; UPREGULATION;

CELL DIVISION; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; CYTOPLASM; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GROWTH SUBSTANCES; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1; LUCIFERASES; MELANOMA; NF-KAPPA B; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0035874609     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Production of multiple cytokines by cultured human melanomas
2. Cytokine expression in human primary and metastatic melanoma cells: Analysis in fresh bioptic specimens
3. Autocrine and paracrine regulation by cytokines and growth factors in melanoma
4. Human melanoma progression in skin reconstructs: Biological significance of bFGF
5. Immunohistochemical evidence of cytokine networks during progression of human lesions
6. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: Evidence for a regulatory role of ultraviolet B, interleukin-1α, interleukin-1β, endothelin-1, and tumour necrosis factor-α
7. IL-8 expression in malignant melanoma: Implications in growth and metastasis
8. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice
9. Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma
10. Expression of IL-8 correlates with the metastatic potential of human melanoma cells in nude mice
11. Effects of MGSA/GROα on melanocyte transformation
12. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine β and γ proteins
13. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor
14. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma
15. Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs294T human melanoma cell line
16. Characterization of autostimulatory and transforming growth factors from human melanoma cells
17. Constitutive overexpression of a growth regulated gene in transformed Chinese hamster and human cells
18. Recombinant expression, biochemical characterization, and biological activities of the human MGSA/GRO protein
19. Neutrophil-activating properties of the melanoma growth-stimulatory activity
20. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2
21. Interleukin-8 and melanoma growth-stimulating activity (MGSA) are induced by ultraviolet B radiation in human keratinocyte cell lines
22. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines
23. Identification of three related human GRO genes encoding cytokine functions
24. Nucleotide sequence of the human melanoma growth stimulatory activity (MGSA) gene
25. Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues
26. Cytokine dysregulation in AIDS: In vivo overexpression of mRNA of tumor necrosis factor-α and its correlation with that of the inflammatory cytokine GRO
27. Expression of the chemokine superfamily in rheumatoid arthritis
28. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes
29. A synthetic peptide inhibitor for α-chemokines inhibits the tumor growth and pulmonary metastasis of human melanoma cells in nude mice
30. Growth control of melanoma cells and melanocytes by cytokines
31. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes
32. The tumorigenic and angiogenic effects of CXCL1/GRO proteins in melanoma
33. Purification of melanoma growth stimulatory activity
34. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes
35. MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells
36. Enhanced degradation of IκBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells
37. Elevated constitutive IκB kinase activity and IκBα phosphorylation in Hs294T melanoma cells leads to increased basal MGSA/GRO-α transcription
38. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κ B
39. NF-κB. Ten years after
40. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
41. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: A mechanism for cytoplasmic retention
42. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: A mechanism for NF-κB activation
43. The NF-κB and IκB proteins: New discoveries and insights
44. Catalysis by a multiprotein IκB kinase complex
45. Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein
46. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
47. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
48. Identification and characterization of an IκB kinase
49. IκB kinase-β. NF-κB activation and complex formation with IκB kinase-α and NIK
50. Direct phosphorylation of IκB by 1KKα and IKKβ: Discrimination between free and NF-κB-bound substrate
51. MAP3K-related kinase involved in NF-κB induction by TNF, CD95, and IL-1
52. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase
53. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176
54. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
55. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation
56. IKK-γ is an essential regulatory subunit of the IκB kinase complex
57. Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis
58. IKKγ mediates the interaction of cellular IκB kinases with the tax transforming protein of human T cell leukemia virus type I
59. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain
60. Enhanced DNA binding and activation of transcription factors NF-κB and AP-1 by acetaldehyde in HEPG2 cells
61. Activation of NF-κB in vivo is regulated by multiple phosphorylations
62. Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice
63. Sulindac inhibits activation of the NF-κB pathway
64. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets
65. Nuclear factor-κB/Rel is apoptogenic in cytokine withdrawal-induced programmed cell death
66. NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis
67. Molecular structure and organization of the human manganese superoxide dismutase gene
68. Autocrine regulation of TPA-induced apoptosis in monoblastic cell-line U-937: Role for TNF-α, MnSOD, and IL-6
69. The NF-κB/Rel family of transcription factors in oncogenic transformation and apoptosis
70. Suppression of TNF-α-induced apoptosis by NF-κB
71. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
72. NF-κB and Rel protein: Evolutionarily conserved mediators of immune responses
73. HTLV-I tax induces cellular proteins that activate the κ B element in the IL-2 receptor α gene
74. Human T cell leukemia virus type I (HTLV-I) and human diseases
75. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer
76. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth
77. Constitutive activation of transcription factors NF-(κ)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines
78. Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells
79. Molecular characterization of melanoma growth stimulatory activity, a growth factor structurally related to β-thromboglobulin
80. Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells